Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Nicotine Chewing Gum × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 1 Neoplasms, Second Primary 1 Behavior, Addictive 1

Interventions

avelumab 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Nicotine Chewing Gum 1 Leucovorin 1 Lenalidomide 1 Irinotecan 1 Interviews as Topic 1 Fluorouracil 1 Cisplatin 1 Cetuximab 1 Bupropion 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡